Blueprint Medicines Corp logo

Blueprint Medicines Corp

FRA:2L9 (USA)  
€ 97.46 (+1.84%) May 24
At Loss
P/B:
20.71
Market Cap:
€ 5.95B ($ 6.46B)
Enterprise V:
€ 5.66B ($ 6.14B)
Volume:
20.00
Avg Vol (2M):
163.00
Also Trade In:

Blueprint Medicines Corp Valuation Measures